Neuromyelitis optica spectrum disorder and rituximab: a multi-center analysis

被引：0
|
作者：
Novi, G. [1 ,2 ]
Capobianco, M. [3 ]
Gallo, F. [4 ]
Mataluni, G. [5 ,6 ]
Signori, A. [4 ]
Laroni, A. [1 ,2 ]
Annovazzi, P. [7 ]
Buttari, F. [8 ]
Rossi, S. [9 ]
Zuliani, L. [10 ]
Sica, F. [8 ]
Cocco, E. [11 ]
Benedetti, L. [1 ,2 ]
Malucchi, S. [3 ]
Frau, J. [11 ]
Sperli, F. [3 ]
Sormani, M. P. [4 ]
机构：
[1] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy
[2] Osped Policlin San Martino, IRCCS, Genoa, Italy
[3] Univ Hosp S Luigi Gonzaga, Reg MS Ctr, Orbassano, Italy
[4] Univ Genoa, Dept Hlth Sci, Genoa, Italy
[5] Univ Tor Vergata, Clin Neurol, Dipartimento Neurosci, Rome, Italy
[6] Fdn Santa Lucia, CERC, Rome, Italy
[7] ASST Valle Olona, Multiple Sclerosis Study Ctr, Gallarate, Italy
[8] IRCCS Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy
[9] IRCCS Fdn Ist Neurol Carlo Besta, Neuroimmunol & Neuromuscular Dis Unit, Milan, Italy
[10] Osped Ca Foncello, AULSS Marca Trevigiana 2, UOC Neurol, Treviso, Italy
[11] Univ Cagliari, Osped Binaghi, Dipartimento Sci Med & Sanita Pubbl, Ctr Sclerosi Multipla, Cagliari, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P846
引用
收藏
页码：436 / 436
页数：1
相关论文
共 50 条
  • [1] Neuromyelitis optica spectrum disorder and Rituximab: a multi-center analysis
    Novi, G.
    Capobianco, M.
    Gallo, F.
    Mataluni, G.
    Signori, A.
    Laroni, A.
    Annovazzi, P.
    Buttari, F.
    Rossi, S.
    Zuliani, L.
    Sica, F.
    Cocco, E.
    Benedetti, L.
    Frau, J.
    Malucchi, S.
    Sperli, F.
    Sormani, M. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 677 - 677
  • [2] Safety and efficacy of rituximab in neuromyelitis optica spectrum disorder
    Radaelli, M.
    Moiola, L.
    Privitera, D.
    Rodegher, M.
    Colombo, B.
    Barcella, V.
    Sangalli, F.
    Esposito, F.
    Comi, G.
    Martinelli, V.
    JOURNAL OF NEUROLOGY, 2011, 258 : 261 - 262
  • [3] Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder
    Nosadini, Margherita
    Alper, Gulay
    Riney, Catherine J.
    Benson, Leslie A.
    Mohammad, Shekeeb S.
    Ramanathan, Sudarshini
    Nolan, Melinda
    Appleton, Richard
    Leventer, Richard J.
    Deiva, Kumaran
    Brilot, Fabienne
    Gorman, Mark P.
    Waldman, Amy T.
    Banwell, Brenda
    Dale, Russell C.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (01):
  • [4] PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
    Nour, Matthew
    Coutinho, Esther
    Nakashima, Ichiro
    Sousa, Filipa
    Woodhall, Mark
    Revis, John
    Santos, Ernestina
    George, Jithin
    Kitley, Joana
    Misu, T.
    Silva, A. M.
    Vincent, Angela
    Palace, Jacqueline
    Waters, Paddy
    Fujihara, K.
    Leite, Maria
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [5] Efficacy and Safety of Rituximab in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Ongphichetmetha, Tatchaporn
    Jitprapaikulsan, Jiraporn
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (09) : NP3 - NP4
  • [6] Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder
    Demuth, Stanislas
    Collongues, Nicolas
    Audoin, Bertrand
    Ayrignac, Xavier
    Bourre, Bertrand
    Ciron, Jonathan
    Cohen, Mikael
    Deschamps, Romain
    Durand-Dubief, Francoise
    Maillart, Elisabeth
    Papeix, Caroline
    Ruet, Aurelie
    Zephir, Helene
    Marignier, Romain
    De Seze, Jerome
    NEUROLOGY, 2023, 101 (04) : E438 - E450
  • [7] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Tatchaporn Ongphichetmetha
    Jiraporn Jitprapaikulsan
    Sasitorn Siritho
    Natthapon Rattanathamsakul
    Thammachet Detweeratham
    Naraporn Prayoonwiwat
    Scientific Reports, 14
  • [8] Relapses shortly after rituximab treatment in neuromyelitis optica spectrum disorder
    Shi, Bingxin
    Zhao, Mangsuo
    Qiao, Liyan
    Huang, Fangjie
    Zhou, Shimei
    Wei, Yan
    Wang, Jing
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 54
  • [9] Effectiveness of Rituximab and Oral Immunosuppressive Therapies in Neuromyelitis Optica Spectrum Disorder
    Abou, Widad
    Dresser, Laura
    Javed, Adil
    ANNALS OF NEUROLOGY, 2022, 92 : S138 - S138
  • [10] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Ongphichetmetha, Tatchaporn
    Jitprapaikulsan, Jiraporn
    Siritho, Sasitorn
    Rattanathamsakul, Natthapon
    Detweeratham, Thammachet
    Prayoonwiwat, Naraporn
    SCIENTIFIC REPORTS, 2024, 14 (01)
12345